These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37852570)

  • 1. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers.
    Guo X; Sun M; Yang P; Meng X; Liu R
    Eur J Pharmacol; 2023 Dec; 960():176103. PubMed ID: 37852570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on mast cells in the tumor microenvironment: Current knowledge and future directions.
    Shi S; Ye L; Yu X; Jin K; Wu W
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188845. PubMed ID: 36476563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast Cells and Resistance to Immunotherapy in Cancer.
    Ribatti D
    Arch Immunol Ther Exp (Warsz); 2023 Apr; 71(1):11. PubMed ID: 37038035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Landscape of Thyroid Cancers: New Insights.
    Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
    Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells as targets for immunotherapy of solid tumors.
    Oldford SA; Marshall JS
    Mol Immunol; 2015 Jan; 63(1):113-24. PubMed ID: 24698842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.
    Ferrari SM; Fallahi P; Galdiero MR; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Varricchi G; Marone G; Antonelli A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells: A double-edged sword in cancer.
    Derakhshani A; Vahidian F; Alihasanzadeh M; Mokhtarzadeh A; Lotfi Nezhad P; Baradaran B
    Immunol Lett; 2019 May; 209():28-35. PubMed ID: 30905824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.
    Kalkusova K; Smite S; Darras E; Taborska P; Stakheev D; Vannucci L; Bartunkova J; Smrz D
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants.
    Willows S; Kulka M
    Cells; 2020 Dec; 9(12):. PubMed ID: 33352850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast Cells in the Tumor Microenvironment.
    Aponte-López A; Muñoz-Cruz S
    Adv Exp Med Biol; 2020; 1273():159-173. PubMed ID: 33119881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
    Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Mast Cell-Derived Adenosine in Cancer.
    Gorzalczany Y; Sagi-Eisenberg R
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of mast cells in anticancer immunity.
    Dalton DK; Noelle RJ
    Cancer Immunol Immunother; 2012 Sep; 61(9):1511-20. PubMed ID: 22527244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast Cells: A New Frontier for Cancer Immunotherapy.
    Lichterman JN; Reddy SM
    Cells; 2021 May; 10(6):. PubMed ID: 34063789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.
    Lu C; Liu Y; Ali NM; Zhang B; Cui X
    Front Immunol; 2022; 13():1039260. PubMed ID: 36741415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive agents targeting tumor microenvironment.
    Sharma SH; Thulasingam S; Nagarajan S
    Life Sci; 2016 Jan; 145():74-84. PubMed ID: 26679106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
    Jiang T; Chen X; Ren X; Yang JM; Cheng Y
    Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.